Legal status · United States
Is Somatostatin legal in the United States?
No. Somatostatin is not an approved medicine in the United States; its classification is "Not approved as a product; analogues (octreotide, lanreotide) are FDA-approved prescription drugs". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. Human evidence: Moderate.
Somatostatin in the United States at a glance
| Classification | Not approved as a product; analogues (octreotide, lanreotide) are FDA-approved prescription drugs |
|---|---|
| FDA approval status | Native hormone; analogues (octreotide) are FDA-approved |
| Evidence level | Moderate (research strength: Strong) |
| Reviewed | Sep 2026 |
Classification and note come from the Somatostatin profile, checked against U.S. Food and Drug Administration (FDA) listings at the reviewed date.
What this means
- 01
No product containing Somatostatin is approved by FDA for any use in the United States, so nothing on the market is authorized for people.
- 02
"Research use only" is a vendor label, not a legal category that permits human use. It does not exempt a product from medicines law.
- 03
Importing, supplying or promoting it for human use can fall under medicines legislation in the United States. This page is general information, not legal advice.
What Somatostatin is
The natural hormone that switches off growth hormone release; its analogues like octreotide are approved drugs.
Somatostatin is the body's natural brake on growth hormone, opposing GHRH and ghrelin. It also suppresses several digestive and pancreatic hormones.
Mechanism: Activates somatostatin receptors to inhibit growth hormone, insulin, glucagon, and various gastrointestinal hormones.
Regulatory history: Native hormone; analogues (octreotide) are FDA-approved
How FDA treats this kind of product
Approves prescription drugs by indication and polices unapproved products, including peptides sold online. Compounding pharmacies may prepare some compounds under a prescription when the FDA places them on a permitted bulk-substances category.
The classification above is the The Longevity Archive reading of U.S. Food and Drug Administration listings for Somatostatin at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Somatostatin in other countries
United Kingdom
Not approvedNot licensed as a product; analogues licensed
Is Somatostatin legal in the United Kingdom?Australia
Not approvedNot registered as a product; analogues registered
Is Somatostatin legal in Australia?Canada
Not approvedNot approved as a product; analogues approved
Is Somatostatin legal in Canada?Frequently asked questions
Is Somatostatin legal in the United States?
No. Somatostatin is not an approved medicine in the United States; its classification is "Not approved as a product; analogues (octreotide, lanreotide) are FDA-approved prescription drugs". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. Human evidence: Moderate.
Can I buy Somatostatin in the United States?
No approved product exists to buy. In the United States Somatostatin is classified as "Not approved as a product; analogues (octreotide, lanreotide) are FDA-approved prescription drugs", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors.
Is Somatostatin FDA approved?
No. FDA status: Native hormone; analogues (octreotide) are FDA-approved. Current US classification: "Not approved as a product; analogues (octreotide, lanreotide) are FDA-approved prescription drugs". Evidence level: Moderate.
Related compounds in the United States
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Somatostatin live on its compound profile.
Somatostatin profileThis page is general information about the regulatory status of Somatostatin in the United States, current as of Sep 2026. It is not legal advice, and classifications change; check U.S. Food and Drug Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.